LYMPHOSTAT Trademark

Trademark Overview

On Thursday, July 12, 2001, a trademark application was filed for LYMPHOSTAT with the United States Patent and Trademark Office. The USPTO has given the LYMPHOSTAT trademark a serial number of 76283658. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Sunday, December 25, 2005. This trademark is owned by Human Genome Sciences, Inc.. The LYMPHOSTAT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of cancers and diseases and disorders of the immune system
lymphostat

General Information

Serial Number76283658
Word MarkLYMPHOSTAT
Filing DateThursday, July 12, 2001
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateSunday, December 25, 2005
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 1, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of cancers and diseases and disorders of the immune system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 23, 2001
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Thursday, March 2, 2006ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Thursday, March 2, 2006ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 21, 2005EXTENSION 5 GRANTED
Tuesday, June 21, 2005EXTENSION 5 FILED
Tuesday, June 21, 2005TEAS EXTENSION RECEIVED
Tuesday, January 11, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 10, 2005EXTENSION 4 GRANTED
Monday, December 20, 2004EXTENSION 4 FILED
Monday, December 20, 2004TEAS EXTENSION RECEIVED
Thursday, July 29, 2004EXTENSION 3 GRANTED
Thursday, June 24, 2004EXTENSION 3 FILED
Monday, July 12, 2004CASE FILE IN TICRS
Thursday, June 24, 2004PAPER RECEIVED
Tuesday, January 20, 2004EXTENSION 2 GRANTED
Friday, December 12, 2003EXTENSION 2 FILED
Friday, December 12, 2003PAPER RECEIVED
Thursday, July 17, 2003EXTENSION 1 GRANTED
Tuesday, June 24, 2003EXTENSION 1 FILED
Tuesday, June 24, 2003PAPER RECEIVED
Friday, February 14, 2003PAPER RECEIVED
Tuesday, December 24, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 1, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 11, 2002NOTICE OF PUBLICATION
Wednesday, June 26, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 24, 2002EXAMINERS AMENDMENT MAILED
Thursday, June 20, 2002PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, June 18, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 20, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 29, 2001NON-FINAL ACTION MAILED
Saturday, August 25, 2001ASSIGNED TO EXAMINER

Related Keywords

lymphostat disorders immune system diseases cancers preparations treatment pharmaceutical